Farcast Biodynamics

Farcast Biodynamics, formerly Farcast Biosciences and earlier associated with the Mitra Biotech name, is a private precision-oncology company focused on human tumor microenvironment research, translational oncology services, and treatment-response prediction. The company uses live human tumor histoculture, multimodal profiling, and AI/ML-based biosignature generation to help biopharma companies evaluate mechanisms of action, identify responder populations, optimize combinations, and support precision-guided clinical development. Farcast also positions its platform for clinical diagnostics and liquid-biopsy-informed applications in oncology. Its commercial offering centers on the TruTumor, TruSign, and TruNet components of the Farcast system, and the company highlights work across immuno-oncology, stromal biology, and engineered immune-cell approaches. Farcast appears to operate as a platform and services business rather than a traditional single-asset therapeutic developer.